Florey Biosciences engineers probiotics using synthetic biology for human health.
Florey Biosciences has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Florey Biosciences is headquartered in Cambridge, United States.
Florey Biosciences engineers probiotics using synthetic biology for human health.
Florey Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Florey Biosciences — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/florey-biosciences. Accessed September 5, 2026.
VCBacked. (2025). Florey Biosciences — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/florey-biosciences
{{cite web |title=Florey Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/florey-biosciences |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated